Novavax's COVID vaccine might be delayed further by additional FDA reviews of its manufacturing process.
Novavax's share price tumbled on Thursday on news the vaccine maker's COVID shot might be delayed further by additional FDA reviews of its manufacturing process.Novavax's shot is in line to become the fourth to be authorized in the U.S.
after an FDA advisory committee concluded the benefits outweighed risks.this week it needs to review changes that Novavax disclosed on June 3 that it had made to its manufacturing process.The company's shares dropped about 17% yesterday, ending the day trading at $41.48.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
SoCal COVID cases rise as rest of nation plateaus, FDA authorizes Novavax vaccine for emergency useIn the Northeast, COVID-19 cases appear to be in a plateau, but what does that mean for Southern California?
続きを読む »
FDA advisers back Novavax COVID-19 vaccine as 4th option for US adultsA more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults.
続きを読む »
FDA Decision on Novavax's Covid Shots Could Be Delayed to Review Changes in ManufacturingThe FDA’s committee recommended the Novavax vaccine for use in the U.S. on Tuesday.
続きを読む »
If You Take This for Your Allergies, Stop Immediately, FDA Warns — Best LifeNottingham, New Hampshire-based Buzzagogo Inc. is voluntarily recalling one lot of its Allergy Bee Gone for Kids Nasal Swab Remedy.
続きを読む »
FDA Decision on Novavax's Covid Shots Could Be Delayed to Review Changes in ManufacturingThe FDA’s committee recommended the Novavax vaccine for use in the U.S. on Tuesday.
続きを読む »
What’s the difference between the Novavax vaccine and others? A doctor breaks it downNow that an FDA advisory committee has recommended the Novavax COVID-19 vaccination for emergency use, experts say we could possibly see the FDA give full approval of the vaccine soon.
続きを読む »